These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9161652)

  • 1. Fluvoxamine for stereotypic behavior in patients with dementia.
    Trappler B; Vinuela LM
    Ann Pharmacother; 1997 May; 31(5):578-81. PubMed ID: 9161652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Stereotyped behaviors and compulsive complaints of pain improved by fluvoxamine in two cases of frontotemporal dementia].
    Ishikawa H; Shimomura T; Shimizu T
    Seishin Shinkeigaku Zasshi; 2006; 108(10):1029-35. PubMed ID: 17240851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of fluvoxamine on behavioral and psychological symptoms of dementia in Alzheimer's disease: a report of three cases.
    Kurita M; Sato T; Nishino S; Ohtomo K; Shirakawa H; Mashiko H; Niwa S; Nakahata N
    Fukushima J Med Sci; 2006 Dec; 52(2):143-8. PubMed ID: 17427765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluvoxamine for psychosis in Alzheimer's disease.
    Levkovitz Y; Bloch Y; Kaplan D; Diskin A; Abramovitchi I
    J Nerv Ment Dis; 2001 Feb; 189(2):126-9. PubMed ID: 11225688
    [No Abstract]   [Full Text] [Related]  

  • 5. [Additional treatment in chronic pain syndrome due to hip and knee arthritis with the selective serotonin reuptake inhibitor fluvoxamine (Fevarin].
    Riesner HJ; Zeitler C; Schreiber H; Wild A
    Z Orthop Unfall; 2008; 146(6):742-6. PubMed ID: 19085723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of risperidone, yokukansan, and fluvoxamine for the treatment of behavioral and psychological symptoms of dementia: a blinded, randomized trial.
    Teranishi M; Kurita M; Nishino S; Takeyoshi K; Numata Y; Sato T; Tateno A; Okubo Y
    J Clin Psychopharmacol; 2013 Oct; 33(5):600-7. PubMed ID: 23948783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment with fluvoxamine against self-injury and aggressive behavior in autistic children].
    Yokoyama H; Hirose M; Haginoya K; Munakata M; Iinuma K
    No To Hattatsu; 2002 May; 34(3):249-53. PubMed ID: 12030015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of antidepressants in the treatment of behavioral and psychological symptoms of dementia, a literature review of evidence.
    Henry G; Williamson D; Tampi RR
    Am J Alzheimers Dis Other Demen; 2011 May; 26(3):169-83. PubMed ID: 21429956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluvoxamine or placebo in the treatment of panic disorder and relationship to blood concentrations of fluvoxamine.
    Sandmann J; Lörch B; Bandelow B; Härtter S; Winter P; Hiemke C; Benkert O
    Pharmacopsychiatry; 1998 Jul; 31(4):117-21. PubMed ID: 9754844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serotonin 2A receptor gene polymorphism and clinical efficacy of fluvoxamine in children with autistic disorder].
    Sugie Y; Sugie H; Fukuda T; Ito M; Ohzeki T
    No To Hattatsu; 2003 Jan; 35(1):23-8. PubMed ID: 12607287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral symptoms in dementia: community-based research.
    Auer SR; Monteiro IM; Reisberg B
    Int Psychogeriatr; 1996; 8 Suppl 3():363-6; discussion 381-2. PubMed ID: 9154589
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical evaluation of treatment with fluvoxamine, a selective serotonin reuptake inhibitor in children with autistic disorder].
    Fukuda T; Sugie H; Ito M; Sugie Y
    No To Hattatsu; 2001 Jul; 33(4):314-8. PubMed ID: 11494573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients.
    Asnis GM; Hameedi FA; Goddard AW; Potkin SG; Black D; Jameel M; Desagani K; Woods SW
    Psychiatry Res; 2001 Aug; 103(1):1-14. PubMed ID: 11472786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of inter-specific aggression in cats with the selective serotonin reuptake inhibitor fluvoxamine. A case report].
    Sprauer S
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(6):438-42. PubMed ID: 23242225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of central poststroke pain with the selective serotonin reuptake inhibitor fluvoxamine.
    Shimodozono M; Kawahira K; Kamishita T; Ogata A; Tohgo S; Tanaka N
    Int J Neurosci; 2002 Oct; 112(10):1173-81. PubMed ID: 12587520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of fluvoxamine in the treatment of major depression with comorbid anxiety disorders.
    Sonawalla SB; Spillmann MK; Kolsky AR; Alpert JE; Nierenberg AA; Rosenbaum JF; Fava M
    J Clin Psychiatry; 1999 Sep; 60(9):580-3. PubMed ID: 10520975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study.
    Stein MB; Fyer AJ; Davidson JR; Pollack MH; Wiita B
    Am J Psychiatry; 1999 May; 156(5):756-60. PubMed ID: 10327910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation adverse events induced by the selective serotonin reuptake inhibitor fluvoxamine in children and adolescents.
    Reinblatt SP; DosReis S; Walkup JT; Riddle MA
    J Child Adolesc Psychopharmacol; 2009 Apr; 19(2):119-26. PubMed ID: 19364290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder.
    McDougle CJ; Naylor ST; Cohen DJ; Volkmar FR; Heninger GR; Price LH
    Arch Gen Psychiatry; 1996 Nov; 53(11):1001-8. PubMed ID: 8911223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral and psychological symptoms of dementia and medical treatment.
    Amano N; Inuzuka S; Ogihara T
    Psychogeriatrics; 2009 Jun; 9(2):45-9. PubMed ID: 19604324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.